"This is changing the way we practice prostate cancer." White House chief of staff Susie Wiles has breast cancer. She'll join ...
Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 million ...
Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...
Jacobs School honors its first international president for relocating the medical campus and advancing regional healthcare innovation.
Among adults with chronic rhinosinusitis with nasal polyps, those receiving verekitug vs. placebo at baseline and week 12 had significantly decreased nasal polyp size at week 24, according to a poster ...
MannKind (MNKD) faces TYVASO DPI royalty risk as United Therapeutics plans TreSMI; expenses rise and pipeline is early.
Functional connectivity reveals brain attractors that match predictions of free‑energy‑minimizing attractor theory, yielding an interpretable generative model of brain dynamics in rest, task, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results